Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $ 
Open $0.36    52 Week Low $ 
Day High $0.36    P/E N/A 
Day Low $0.36    EPS $ 
Volume 11,233